BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9894479)

  • 1. Are there site-specific differences among extranodal aggressive B-cell neoplasms?
    Mann RB
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S144-50. PubMed ID: 9894479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
    López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
    J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extranodal lymphomas of the head and neck.
    Vega F; Lin P; Medeiros LJ
    Ann Diagn Pathol; 2005 Dec; 9(6):340-50. PubMed ID: 16308165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.
    Soslow RA; Baergen RN; Warnke RA
    Cancer; 1999 Jun; 85(12):2648-54. PubMed ID: 10375114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse large B-cell lymphoma and its variants.
    Dominis M; Dzebro S; Gasparov S; Pesut A; Kusec R
    Croat Med J; 2002 Oct; 43(5):535-40. PubMed ID: 12402391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Extranodal Lymphomas.
    Gospodarowicz MK; Sutcliffe SB
    Semin Radiat Oncol; 1995 Oct; 5(4):281-300. PubMed ID: 10717152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extranodal malignant lymphoma of the upperaerodigestive tract in King Chulalongkorn Memorial Hospital according to WHO classification.
    Assanasen T; Wannakrairot P; Keelawat S; Pramprayoon N; Chaipipat M
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S249-54. PubMed ID: 16083197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation.
    Lin P; Molina TJ; Cook JR; Swerdlow SH
    Am J Clin Pathol; 2011 Aug; 136(2):195-210. PubMed ID: 21757593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aspects in the biology of cutaneous B-cell lymphomas.
    Pimpinelli N
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():6-9. PubMed ID: 16412207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin lymphomas of mice.
    Hori M; Xiang S; Qi CF; Chattopadhyay SK; Fredrickson TN; Hartley JW; Kovalchuk AL; Bornkamm GW; Janz S; Copeland NG; Jenkins NA; Ward JM; Morse HC
    Blood Cells Mol Dis; 2001; 27(1):217-22. PubMed ID: 11358382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular lymphoma: the oncologist's "great imitator".
    Zuckerman D; Seliem R; Hochberg E
    Oncologist; 2006 May; 11(5):496-502. PubMed ID: 16720850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification.
    Baars JW; de Jong D; Willemse EM; Gras L; Dalesio O; v Heerde P; Huygens PC; vd Lelie H; Kr vd Borne AE
    Br J Cancer; 1999 Apr; 79(11-12):1770-6. PubMed ID: 10206291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive B-cell lymphomas with a primary bone marrow presentation.
    Zamò A; Johnston P; Attygalle AD; Laurent C; Arber DA; Fend F
    Histopathology; 2020 Sep; 77(3):369-379. PubMed ID: 32324290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New aspects in the classification of cutaneous lymphomas].
    Erós N; Károlyi Z; Kovács A
    Orv Hetil; 2001 Feb; 142(8):393-8. PubMed ID: 11263077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extranodal diffuse large B-cell lymphoma--an organotypic disease?].
    Ott G; Rosenwald A
    Pathologe; 2007 Feb; 28(1):29-35. PubMed ID: 17211671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.
    Campo E; Chott A; Kinney MC; Leoncini L; Meijer CJ; Papadimitriou CS; Piris MA; Stein H; Swerdlow SH
    Histopathology; 2006 Apr; 48(5):481-504. PubMed ID: 16623775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal lymphomas of T- and B-cell types.
    Isaacson PG
    Mod Pathol; 1999 Feb; 12(2):151-8. PubMed ID: 10071340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
    Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
    Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.